A nurse is caring for a client with a prescription for levothyroxine. When should the nurse instruct the client to take this medication?

A. A client with a low serum albumin: Low albumin levels affect protein binding of highly protein-bound drugs, increasing the free drug concentration and potential toxicity. While this influences drug distribution and effects, it does not directly impair hepatic metabolism.

B. A client diagnosed with renal failure: Renal failure primarily affects drug excretion rather than metabolism. Drugs cleared by the kidneys may accumulate, but hepatic metabolism may remain largely intact unless concomitant liver disease is present.

C. A client with slowed gastric emptying: Slowed gastric emptying affects the rate and sometimes the extent of drug absorption. While this can delay onset of action, it does not significantly alter hepatic metabolism of the medication.

D. A client with cirrhosis of the liver: Cirrhosis significantly impairs hepatic function, reducing the liver’s ability to metabolize drugs through phase I and phase II reactions. This increases drug half-life, risk of accumulation, and potential toxicity, making these clients the highest risk for decreased drug metabolism.

A. Decreased gastric pH: A lower gastric pH primarily affects drug absorption by altering solubility and ionization of medications in the stomach. It does not directly influence the distribution phase of pharmacokinetics, which relates to how the drug moves throughout body compartments.

B. Decreased levels of microsomal enzymes: Reduced hepatic microsomal enzyme activity affects drug metabolism, particularly phase I reactions, but does not directly impact distribution. Metabolic changes alter the duration and intensity of drug effects rather than how the drug is distributed in the body.

C. Fewer intact nephrons: A decline in functional nephrons primarily affects drug excretion. Impaired renal elimination can lead to drug accumulation, but distribution is determined by tissue compartments, protein binding, and body water/fat content.

D. Decrease percentage of total body water: Aging decreases total body water, which affects the volume of distribution for hydrophilic drugs. Lower water content leads to higher plasma concentrations of water-soluble drugs, increasing the risk of toxicity and altering therapeutic effects in older adults.